9 November 2026 - Global law firm Hogan Lovells Cadwalader, led by partners Dr. Nikolas Zirngibl and Dr. Christoph Wünschmann, has advised Organigram Global Inc. on the planned acquisition of Aurora Cannabis Inc. The combination creates a global market leader in the cannabis sector with a strong position in Canada, Europe and Australia.

Under the arrangement agreement, Organigram will acquire all issued and outstanding common shares of Aurora at a price of CAD7.80 per share. The transaction values Aurora at approximately CAD561 million.

Together, the companies, both headquartered in Canada, will create a global cannabis champion with a leading market position in Canada, Europe and Australia and a growing presence in further key regions. Organigram is the market leader in the adult-use cannabis segment and contributes its production network, its R&D platform and its European medical cannabis business. Aurora adds its global leadership in medical cannabis and its established international presence. The combined company owns and operates five EU-GMP-certified production and distribution facilities.

The boards of both companies have unanimously approved the transaction. Closing remains subject to shareholder approval as well as court and regulatory approvals and is expected in January 2027.

The Hogan Lovells Cadwalader cross-border team advised Organigram comprehensively on due diligence and on the antitrust, merger control and foreign investment control aspects of the transaction.

Canadian law firm Goodmans LLP acted as lead transaction counsel to Organigram.

Hogan Lovells Cadwalader team for Organigram
Dr. Nikolas Zirngibl (Partner), Hannah Logan (Partner), Dr. Dominik Lang (Senior Associate), Jasper Lohse, Nico Bär (Associates), Sonia Doal (Trainee) (Corporate / M&A, Munich, London);
Dr. Christoph Wünschmann (Partner), Dr. Friedrich Preetz, Julius Jakob Gertz (Associates) (Antitrust / Merger Control, Munich, Brussels);
Jane Summerfield (Partner), Dr. Tina Welter-Birk (Counsel), Bea Watts (Senior Associate) (Life Sciences / Pharmaceuticals, London, Munich);
Dr. Martin Pflüger (Partner), Sebastian Eisenberger (Senior Associate) (Data Protection, Munich);
Martin Günther (Partner), Dr. Tim Hinrichsen (Counsel), Sven Maier (Senior Associate) (Real Estate, Munich)

In-house team Organigram
Helen Martin (Chief Legal Officer), Pierre-Luc Michaud (Senior Legal Counsel)

Holding Redlich, Australia: Ben Constance
DWF, Poland: Beata Balas-Noszczyk, Tomasz Grygorczuk
Simpson Grierson, New Zealand: Simon Vannini

This text was automatically translated from the German original.